Analysis The Price-fixing Claims Look Worse for Teva Than They Really Are

It’s a nasty business but the financial impact on Teva is containable and the bigger picture for the troubled drug maker is looking brighter

comments Print
You might think that after hearing the news about a massive price-fixing lawsuit against Teva Pharmaceuticals, its CEO K re Schultz is ready to pack his bags and go back to a peaceful life in Denmark.